• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Mexico to use only Pfizer COVID-19 vaccine on at-risk kids

September 24, 2021 by David Barret Leave a Comment

September 24, 2021

MEXICO CITY (Reuters) -The COVID-19 vaccine by Pfizer-BioNTech will be the only one used in Mexico for at-risk children aged 12-17, Mexico’s deputy health minister said on Friday.

Mexico is expanding its vaccine campaign to children with health issues like cancer, diabetes or cardiovascular disease that make them vulnerable to the virus.

“We can only use the Pfizer-BioNTech vaccine because it is the only one that has already been scientifically proven to be safe and effective in girls, boys and adolescents from 12 to 17 years old,” Deputy Health Minister Hugo Lopez-Gatell said at a regular news conference.

“It is not ruled out that other pharmaceutical companies in due course also present their analysis and demonstrate the vaccines can also be used in children and adolescents,” he added.

The government estimates it will give vaccines to between 750,000 and 1.5 million at-risk children initially.

Mexico has applied so far for 97.5 million vaccine doses, according to government data. About 43.2 million people are fully vaccinated among its population of 126 million.

Mexico has recorded 3,608,976 infections and 274,139 related deaths since the pandemic began. However health ministry officials have previously said that the real coronavirus numbers are likely significantly higher.

(Reporting by Cassandra Garrison; editing by Philippa Fletcher and Mark Porter)

Source Link Mexico to use only Pfizer COVID-19 vaccine on at-risk kids

David Barret
David Barret

Related posts:

  1. India looking to tax cryptocurrency trades and ecosystem in the country -ET Now
  2. Apple shares recover ground after Epic ruling slide
  3. A reluctant feminist: Germany’s Merkel still inspires many women
  4. What to make of Freshworks’ first IPO price range

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • US Just Killed NASA’s Mars Sample Return Mission – So What Happens Now?
  • Art Sleuths May Have Recovered Traces Of Da Vinci’s DNA From One Of His Drawings
  • Countries With The Most Narcissists Identified By 45,000-Person Study, And The Results Might Surprise You
  • World’s Oldest Poison Arrows Were Used By Hunters 60,000 Years Ago
  • The Real Reason You Shouldn’t Eat (Most) Raw Cookie Dough
  • Antarctic Scientists Have Just Moved The South Pole – Literally
  • “What We Have Is A Very Good Candidate”: Has The Ancestor Of Homo Sapiens Finally Been Found In Africa?
  • Europe’s Missing Ceratopsian Dinosaurs Have Been Found And They’re Quite Diverse
  • Why Don’t Snorers Wake Themselves Up?
  • Endangered “Northern Native Cat” Captured On Camera For The First Time In 80 Years At Australian Sanctuary
  • Watch 25 Years Of A Supernova Expanding Into Space Squeezed Into This 40-Second NASA Video
  • “Diet Stacking” Trend Could Be Seriously Bad For Your Health
  • Meet The Psychedelic Earth Tiger, A Funky Addition To “10 Species To Watch” In 2026
  • The Weird Mystery Of The “Einstein Desert” In The Hunt For Rogue Planets
  • NASA Astronaut Charles Duke Left A Touching Photograph And Message On The Moon In 1972
  • How Multilingual Are You? This New Language Calculator Lets You Find Out In A Minute
  • Europa’s Seabed Might Be Too Quiet For Life: “The Energy Just Doesn’t Seem To Be There”
  • Amoebae: The Microscopic Health Threat Lurking In Our Water Supplies. Are We Taking Them Seriously?
  • The Last Dogs In Antarctica Were Kicked Out In April 1994 By An International Treaty
  • Interstellar Comet 3I/ATLAS Snapped By NASA’s Europa Mission: “We’re Still Scratching Our Heads About Some Of The Things We’re Seeing”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2026 · Medical Market Report. All Rights Reserved.

Go to mobile version